Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) issued its quarterly earnings results on Thursday. Aligos Therapeutics Stock PerformanceALGS traded up $0.08 on Friday, hitting $5.59. Aligos Therapeutics has a 12-month low of $3.98 and a 12-month high of $13.69. Get Aligos Therapeutics alerts:Institutional Inflows and OutflowsInstitutional investors and hedge funds have recently modified their holdings of the company. See AlsoReceive News & Ratings for Aligos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aligos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.